Loading clinical trials...
Loading clinical trials...
Neoadjuvant systemic therapy (NST) is increasingly recommended for patients with early breast cancer, and the rate of patients with pathological complete remission (pCR) is increasing due to the use o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kliniken Essen-Mitte
NCT01840293 · Primary Breast Cancer, Recurrent/Metastatic Breast Cancer
NCT04622319 · HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer
NCT06954532 · Cancer, Primary Breast Cancer
NCT05923177 · Primary Breast Cancer
NCT02214381 · Early Primary Breast Cancer
Interdisciplinary Breast Unit, Kliniken Essen-Mitte
Essen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions